|
BKNM-R-12254
N/A |
|
MMPs-peg-MMPs polyethylene glycol modified double MMPs
|
¥Member visible
|
|
BKNM-R-12253
N/A |
|
RVG29-peg-RVG29 polyethylene glycol modified double brain targeting peptide
|
¥Member visible
|
|
BKNM-R-12252
N/A |
|
Pep-1-peg-Pep-1 polyethylene glycol modified double Pep-1
|
¥Member visible
|
|
BKNM-R-12251
N/A |
|
WSW-peg-WSW polyethylene glycol modified double WSW peptide
|
¥Member visible
|
|
BKNM-R-12250
N/A |
|
YIGSR-peg-YIGSR polyethylene glycol modified anti-adhesion peptide
|
¥Member visible
|
|
BKNM-R-12249
N/A |
|
RVG29-peg-RVG29 polyethylene glycol modified double brain targeting peptide
|
¥Member visible
|
|
BKNM-R-12248
N/A |
|
GE11-peg-GE11 polyethylene glycol modified GE11
|
¥Member visible
|
|
BKNM-R-12246
N/A |
|
CCK8-peg-CCK8 polyethylene glycol modified double CCK8
|
¥Member visible
|
|
BKNM-R-12247
N/A |
|
CTT2-peg-CTT2 polyethylene glycol modified double CTT2
|
¥Member visible
|
|
BKNM-R-12245
N/A |
|
CPP-peg-CPP polyethylene glycol modified double cell penetrating peptide
|
¥Member visible
|
|
BKNM-R-12244
N/A |
|
SP94-peg-SP94 polyethylene glycol modified double SP94
|
¥Member visible
|
|
BKNM-R-12243
N/A |
|
Octreotide-peg-Octreotide Octreotide-peg-Octreotide
|
¥Member visible
|
|
BKNM-R-12242
N/A |
|
TAT-peg-TAT polyethylene glycol modified double cell penetrating peptide
|
¥Member visible
|
|
BKNM-R-12240
N/A |
|
RGD-peg-RGD same-end peptide
|
¥Member visible
|
|
BKNM-R-12239
N/A |
|
ISC-peg-ISC isocyanate PEG isocyanate
|
¥Member visible
|
|
BKNM-R-12238
N/A |
|
ITC-peg-ITC lectin-polyethylene glycol-lectin
|
¥Member visible
|
|
BKNM-R-12237
N/A |
|
RA-peg- RA Retinoic acid-polyethylene glycol-retinoic acid
|
¥Member visible
|
|
BKNM-R-12236
N/A |
|
DTPA-peg-DTPA bisdiethyltriaminepentaacetic acid
|
¥Member visible
|
|
BKNM-R-12235
N/A |
|
NOTA-PEG-NOTA Bistritetraazacyclic Ligand
|
¥Member visible
|
|
BKNM-R-12234
N/A |
|
DOTA-peg-DOTA double tetraazacyclododecane polyethylene glycol
|
¥Member visible
|